Form 4 for BSX Boston Scientific
Accepted 2024-11-27 00:00:00 ET · period of report 2024-11-26 · accession 0001225208-24-010259 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-11-27 | 2024-11-26 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | G - Gift | $0.00 | -7,800 | 201.5K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-26 | G | D | 7,800 | $0.00 | 201,478 | I By Trust | — | — |